$83.45
-0.69-0.82%
At close: -
$84.32
0.871.04%
After Hours: Dec 20, 4:09 PM EDT
Comments
Loading...
Intra-Cellular Therapies (ITCI) Forecast
NewsEarningsIntra-Cellular Therapies (ITCI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestIntra-Cellular Therapies (NASDAQ:ITCI) Stock Quotes, Forecast and News Summary
Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Intra-Cellular Therapies (ITCI) stock?
You can purchase shares of Intra-Cellular Therapies (NASDAQ:ITCI) through any online brokerage.
Who are Intra-Cellular Therapies (ITCI) competitors?
Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
What is the forecast, or price target, for Intra-Cellular Therapies (ITCI) stock?
Intra-Cellular Therapies has a consensus price target of $94.40.
What is the current price for Intra-Cellular Therapies (ITCI)?
The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $84.32 last updated December 20, 2024 at 4:09 PM EST.
Does Intra-Cellular Therapies (ITCI) pay a dividend?
There are no upcoming dividends for Intra-Cellular Therapies.
When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?
Intra-Cellular Therapies’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Intra-Cellular Therapies (ITCI) going to split?
There is no upcoming split for Intra-Cellular Therapies.
What sector and industry does Intra-Cellular Therapies (ITCI) operate in?
Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.